ORIC Pharmaceuticals, Inc. (ORIC) Stock Grade

About ORIC Pharmaceuticals, Inc.'s fundamentals

ORIC Pharmaceuticals is a biotech company with a market capitalization of $718.2 million that reported zero revenue growth year-over-year and operates at a net margin of 0.0%, reflecting a net loss in its latest annual statement. The company has no dividend yield and traditional valuation metrics like P/E ratio and return on equity are not applicable given its current financial position. As an early-stage biotech firm, ORIC's financial performance is typical of companies in development stages that are not yet profitable and may be pre-revenue or generating minimal commercial returns.